These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4809253)

  • 1. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.
    French FA; Blanz EJ; Shaddix SC; Brockman RW
    J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential antitumor agents. 6. Possible irreversible inhibitors of ribonucleoside diphosphate reductase.
    Agrawal KC; Booth BA; Moore EC; Sartorelli AC
    J Med Chem; 1972 Nov; 15(11):1154-8. PubMed ID: 4347551
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazones.
    Mooney PD; Booth BA; Moore EC; Agrawal KC; Sartorelli AC
    J Med Chem; 1974 Nov; 17(11):1145-50. PubMed ID: 4370274
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential antitumor agents. 9. 2-Formyl(m-amino)phenylpyridine thiosemicarbazones.
    Agrawal KC; Lin AJ; Booth BA; Wheaton JR; Sartorelli AC
    J Med Chem; 1974 Jun; 17(6):631-5. PubMed ID: 4857315
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
    Booth BA; Agrawal KC; Moore EC; Sartorelli AC
    Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
    [No Abstract]   [Full Text] [Related]  

  • 6. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
    Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
    Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antitumor agents. 11. Inhibitors of alkaline phosphatase, an enzyme involved in the resistance of neoplastic cells to 6-thiopurines.
    Agrawal KC; Lee MH; Booth BA; Moore EC; Sartorelli AC
    J Med Chem; 1974 Sep; 17(9):934-8. PubMed ID: 4370275
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential antitumor agents. IV. 4-substituted 1-formylisoquinoline thiosemicarbazones.
    Agrawal KC; Cushley RJ; McMurray WJ; Sartorelli AC
    J Med Chem; 1970 May; 13(3):431-4. PubMed ID: 5466487
    [No Abstract]   [Full Text] [Related]  

  • 9. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
    Mihich E; Nichol CA
    Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential antitumor agents. 7. 4'-Diethyleneoxy derivatives of -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
    Agrawal KC; Booth BA; Sartorelli AC
    J Med Chem; 1973 Jun; 16(6):715-7. PubMed ID: 4715010
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential antitumor agents. 5. Methylated -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
    Agrawal KC; Cushley RJ; Lipsky SR; Wheaton JR; Sartorelli AC
    J Med Chem; 1972 Feb; 15(2):192-5. PubMed ID: 5008241
    [No Abstract]   [Full Text] [Related]  

  • 12. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterocyclic thiosemicarbazones and related derivatives. Synthesis and screening data.
    Giner-Sorolla A; McCravey M; Longley-Cook J; Burchenal JH
    J Med Chem; 1973 Sep; 16(9):984-8. PubMed ID: 4745514
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VII. 2-Formylpyridine derivatives bearing additional ring substituents.
    Blanz EJ; French FA; DoAmaral JR; French DA
    J Med Chem; 1970 Nov; 13(6):1124-30. PubMed ID: 5273758
    [No Abstract]   [Full Text] [Related]  

  • 16. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.
    French FA; Blanz EJ; DoAmaral JR; French DA
    J Med Chem; 1970 Nov; 13(6):1117-24. PubMed ID: 5273757
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy studies on experimental mouse tumors. X.
    French FA; Blanz EJ
    Cancer Chemother Rep 2; 1971 Apr; 2(1):199-235. PubMed ID: 5565536
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antitumor activity of 3- and 5-hydroxy-4-methylpyridine-2-carboxaldehyde thiosemicarbazones.
    Wang Y; Liu MC; Lin TS; Sartorelli AC
    J Med Chem; 1992 Oct; 35(20):3667-71. PubMed ID: 1433177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential antitumor agents. 8. Derivatives of 3- and 5-benzyloxy-2-formylpyridine thiosemicarbazone.
    Lin AJ; Agrawal KC; Sartorelli AC
    J Med Chem; 1972 Jun; 15(6):615-8. PubMed ID: 5030928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.